Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis
GLP-1 medications like semaglutide face scrutiny over compounded versions, raising concerns about patient safety and counterfeit products in diabetes treatment.
Solving the Mental Health Gap with Prescription Digital Therapeutics
Prescription digital therapeutics (PDTs) offer scalable, accessible alternatives to traditional treatments—supporting patients, providers, and payers while addressing gaps in mental…
Elevated Remnant Cholesterol, Lp-PLA2 Linked to Heightened Risk of Composite Adverse Events
Stroke, myocardial infarction, and all-cause death were included in the composite of adverse cardiovascular events.
Hospitalized Adults With Community-Acquired Pneumonia Suffer Significant Morbidity Postdischarge
Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability…
Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product
Real-world data shows patients switching from Humira to biosimilars Hadlima and Hyrimoz achieve similar outcomes without hospitalization.
Shingles and RSV Vaccines Show Promise Against Dementia
Recent research reveals that RSV and shingles vaccines significantly lower dementia risk, highlighting the potential benefits of AS01 adjuvants in…
Senate removes PBM provision from tax and spending bill
House Republicans are reportedly expected to pass President Donald Trump’s spending bill today after holding a marathon voting session during…
Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, discusses the new outpatient transplant program at Atrium Health Wake Forest Baptist in North…
Sharp HealthCare reduces workforce by 1.5%, cites economy
Citing changing economic conditions, Sharp HealthCare has announced it will be cutting 315 employees from its payrolls as part of…